Your browser doesn't support javascript.
loading
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.
Harbeck, Nadia; Kates, Ronald; Schinköthe, Timo; Schumacher, Johannes; Wuerstlein, Rachel; Degenhardt, Tom; Lüftner, Diana; Räth, Philip; Hoffmann, Oliver; Lorenz, Ralf; Decker, Thomas; Reinisch, Mattea; Göhler, Thomas; Staib, Peter; Gluz, Oleg; Fasching, Peter A; Schmidt, Marcus.
Afiliación
  • Harbeck N; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany; West German Study Group, Moenchengladbach, Germany. Electronic address: nadia.harbeck@med.uni-muenchen.de.
  • Kates R; West German Study Group, Moenchengladbach, Germany.
  • Schinköthe T; CANKADO GmbH, Ottobrunn, Germany; Research Center Smart Digital Health, University of the Bundeswehr Munich, Neubiberg, Germany.
  • Schumacher J; palleos healthcare GmbH, Wiesbaden, Germany.
  • Wuerstlein R; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany; West German Study Group, Moenchengladbach, Germany.
  • Degenhardt T; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany; Hausarztpraxis Wolfratshausen, Wolfratshausen, Germany.
  • Lüftner D; Immanuel Hospital Märkische, Schweiz Buckow, Germany; Immanuel Hospital Rüdersdorf and Medical University of Brandenburg Theodor Fontane, Germany.
  • Räth P; palleos healthcare GmbH, Wiesbaden, Germany.
  • Hoffmann O; University Hospital Essen, Breast Center, Essen, Germany.
  • Lorenz R; Studien GbR Braunschweig, Braunschweig, Germany.
  • Decker T; Onkologie Ravensburg, Hematology / Oncology, Ravensburg, Germany.
  • Reinisch M; Breast Center, Kliniken Essen-Mitte, Essen, Germany; Charité - Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Berlin, Germany.
  • Göhler T; Onkozentrum Dresden, Dresden, Germany.
  • Staib P; St.-Antonius Hospital gGmbH, Clinic for Hematology and Oncology, Eschweiler, Germany.
  • Gluz O; West German Study Group, Moenchengladbach, Germany.
  • Fasching PA; University Hospital Erlangen, Obstetrics and Gynecology, Erlangen, Germany.
  • Schmidt M; Department of Obstetrics and Gynecology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Cancer Treat Rev ; 121: 102631, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37862832
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos